| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |